Theratechnologies Stock Analysis

TH Stock  CAD 1.85  0.03  1.65%   
Theratechnologies is overvalued with Real Value of 1.52 and Hype Value of 1.87. The main objective of Theratechnologies stock analysis is to determine its intrinsic value, which is an estimate of what Theratechnologies is worth, separate from its market price. There are two main types of Theratechnologies' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Theratechnologies' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Theratechnologies' stock to identify patterns and trends that may indicate its future price movements.
The Theratechnologies stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Theratechnologies is usually not traded on Canada Day, Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. Theratechnologies Stock trading window is adjusted to America/Toronto timezone.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.

Theratechnologies Stock Analysis Notes

About 52.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.06. Theratechnologies last dividend was issued on the 18th of October 2000. The entity had 1:4 split on the 31st of July 2023. Theratechnologies Inc., a biopharmaceutical company, markets prescription products in the United States, Europe, and Canada. The company was founded in 1993 and is headquartered in Montreal, Canada. THERATECHNOLOGIES operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. It employs 42 people. To find out more about Theratechnologies contact Paul Lvesque at 514 336 7800 or learn more at https://www.theratech.com.

Theratechnologies Quarterly Total Revenue

22.6 Million

Theratechnologies Investment Alerts

Theratechnologies may become a speculative penny stock
Theratechnologies had very high historical volatility over the last 90 days
Theratechnologies has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 81.76 M. Net Loss for the year was (23.96 M) with profit before overhead, payroll, taxes, and interest of 56.22 M.
Theratechnologies has accumulated about 9.21 M in cash with (5.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35.
Latest headline from news.google.com: Theratechnologies Inc. Sees Large Growth in Short Interest - MarketBeat

Theratechnologies Largest EPS Surprises

Earnings surprises can significantly impact Theratechnologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-10-08
2019-08-31-0.01-0.02-0.01100 
2018-02-07
2017-11-30-0.02-0.03-0.0150 
2017-10-05
2017-08-31-0.03-0.04-0.0133 
View All Earnings Estimates

Theratechnologies Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.06 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Theratechnologies's market, we take the total number of its shares issued and multiply it by Theratechnologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Theratechnologies Profitablity

Theratechnologies' profitability indicators refer to fundamental financial ratios that showcase Theratechnologies' ability to generate income relative to its revenue or operating costs. If, let's say, Theratechnologies is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Theratechnologies' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Theratechnologies' profitability requires more research than a typical breakdown of Theratechnologies' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.42)(0.44)
Return On Capital Employed(0.31)(0.33)
Return On Assets(0.35)(0.37)
Return On Equity 1.32  1.39 

Management Efficiency

Theratechnologies has return on total asset (ROA) of 0.1176 % which means that it generated a profit of $0.1176 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (11.1686) %, meaning that it generated substantial loss on money invested by shareholders. Theratechnologies' management efficiency ratios could be used to measure how well Theratechnologies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 4th of December 2024, Return On Equity is likely to grow to 1.39, while Return On Tangible Assets are likely to drop (0.44). At this time, Theratechnologies' Non Current Assets Total are very stable compared to the past year. As of the 4th of December 2024, Other Assets is likely to grow to about 2.2 M, while Total Assets are likely to drop about 65.2 M.
Last ReportedProjected for Next Year
Book Value Per Share(0.91)(0.87)
Tangible Book Value Per Share(1.46)(1.38)
Enterprise Value Over EBITDA(7.77)(8.16)
Price Book Value Ratio(1.80)(1.71)
Enterprise Value Multiple(7.77)(8.16)
Price Fair Value(1.80)(1.71)
Enterprise Value59.9 M56.9 M
Understanding the operational decisions made by Theratechnologies management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Operating Margin
0.2749
Profit Margin
(0.04)
Beta
1.725
Return On Assets
0.1176
Return On Equity
(11.17)

Technical Drivers

As of the 4th of December, Theratechnologies has the Risk Adjusted Performance of 0.0435, coefficient of variation of 2132.53, and Semi Deviation of 3.26. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Theratechnologies, as well as the relationship between them.

Theratechnologies Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Theratechnologies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Theratechnologies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Theratechnologies Outstanding Bonds

Theratechnologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Theratechnologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Theratechnologies bonds can be classified according to their maturity, which is the date when Theratechnologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Theratechnologies Predictive Daily Indicators

Theratechnologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Theratechnologies stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Theratechnologies Forecast Models

Theratechnologies' time-series forecasting models are one of many Theratechnologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Theratechnologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Theratechnologies Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Theratechnologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Theratechnologies shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Theratechnologies. By using and applying Theratechnologies Stock analysis, traders can create a robust methodology for identifying Theratechnologies entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.26)(0.27)
Operating Profit Margin(0.13)(0.12)
Net Loss(0.26)(0.28)
Gross Profit Margin 0.87  0.96 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Theratechnologies to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Earnings Calls Now

   

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module
When determining whether Theratechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theratechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theratechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theratechnologies Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Please note, there is a significant difference between Theratechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theratechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theratechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.